By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agios Pharmaceuticals 

38 Sidney Street
2nd Floor
Cambridge  Massachusetts  02139-4169  U.S.A.
Phone: 617-649-8600 Fax: n/a


SEARCH JOBS

Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic metabolic disorders through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class investigational medicines in clinical and/or preclinical development. All Agios programs focus on genetically identified patient populations, leveraging our knowledge of metabolism, biology and genomics. For more information, please visit the company's website at www.agios.com.

YEAR FOUNDED:

August 7, 2007

LEADERSHIP:

Founders: Lewis Cantley, Tak Mak, Craig Thompson, Shin-San Michael Su

CEO: David Schenkein

CMO (Medical): Chris Bowden

CSO (Scientific): Scott Biller

JOBS:

Please click here for Agios job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email:
Ownership: Public

Web Site: Agios
Employees:
Symbol: AGIO
 









Company News
Agios (AGIO) Announces Closing Of Public Offering And Full Exercise Of Option To Purchase Additional Shares 9/21/2016 10:54:35 AM
Agios (AGIO) Announces Pricing Of $150 Million Public Offering Of Common Stock 9/15/2016 8:54:35 AM
Agios (AGIO) Announces Proposed Offering Of Common Stock 9/14/2016 10:20:28 AM
Another Celgene (CELG) Bet Pays Off as Agios (AGIO) Eyes Early Approval of Leukemia Drug 9/7/2016 6:12:05 AM
Agios (AGIO) To Present At Morgan Stanley Global Healthcare Conference Tuesday, September 13, 2016 9/6/2016 10:24:34 AM
Former BIND Therapeutics (BIND) CEO Joins Agios (AGIO) as New CFO 8/16/2016 6:53:50 AM
Agios (AGIO) To Present At Canaccord Genuity 36th Annual Growth Conference Wednesday, August 10, 2016 8/5/2016 10:09:00 AM
Agios (AGIO) Reports Second Quarter 2016 Financial Results 8/4/2016 11:26:20 AM
Agios (AGIO)' Anemia Drug Data Hits Mark in Mid-Stage Study 6/13/2016 7:28:20 AM
Agios (AGIO) Reports Initial Data From Phase I Study Of AG-519 In Healthy Volunteers 6/9/2016 1:35:43 PM
12345678910...
//-->